Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2025 14:48 ET | Source: BCC Research LLC

China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030

Boston, Oct. 31, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “The Chinese Market for DNA Sequencing” is projected to grow from $1.2 billion in 2025 to $3.1 billion by...
October 29, 2025 14:12 ET | Source: BCC Research LLC

mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030

Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “mRNA: Therapeutics and Global Markets” is forecast to remain stable or slightly decline to $7.69 billion...
October 15, 2025 11:39 ET | Source: Eascra Biotech

Eascra Biotech Named to Fast Company’s “Next Big Things in Tech 2025”

Fast Company has named Eascra Biotech, a nanomedicine startup, to its annual Next Big Things in Tech list for 2025.
October 14, 2025 07:30 ET | Source: Aanastra Inc

Aanastra Inc Announces Presentations of Preclinical Data at Upcoming Conferences in Support of its Lead Programs for Anti-CD19 In Vivo CAR-T (AAN-14x) and In vivo Rescue of P53 Mutations in Tumors (AAN-53x)

Aanastra Inc to present preclinical data for in vivo CAR-T and p53 RNA programs leveraging its proprietary PEP-NP™ peptide delivery technology
September 02, 2025 15:06 ET | Source: Association of American Physicians and Surgeons

Harms from Modified mRNA COVID-19 Vaccines Discussed in the Journal of American Physicians and Surgeons

While mRNA biologics are a transformative frontier, modified mRNA COVID vaccines can disrupt every body system. Urgent scrutiny and acountability needed.
August 11, 2025 14:54 ET | Source: Global Virus Network

Global Virus Network Reaffirms Support for mRNA Vaccines and Collaborative Vaccine Research

GVN is committed to continued development & deployment of mRNA vaccines & the global scientific collaboration that makes innovation possible.
June 12, 2025 06:45 ET | Source: BioNTech SE

BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an

Die geplante Übernahme soll die Forschung, Entwicklung, Herstellung und Kommerzialisierung von mRNA-basierten Krebsimmuntherapie-Kandidaten stärken und ist ein weiterer wichtiger Meilenstein in der...
June 12, 2025 06:45 ET | Source: BioNTech SE

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its...
June 11, 2025 06:30 ET | Source: Research and Markets

Messenger RNA Market Research Report 2025-2035, Competitive Analysis of Pfizer, GSK, Arcturus Therapeutics, AstraZeneca, Beam Therapeutics, Moderna, Oncotelic, SK Bioscience, Sangamo, Sanofi CureVac

Dublin, June 11, 2025 (GLOBE NEWSWIRE) -- The "Messenger RNA Market - A Global and Regional Analysis: Focus on Application and Regional Analysis - Analysis and Forecast, 2025-2035" report has been...
June 10, 2025 04:30 ET | Source: Custom Market Insights

[Latest] Global Neoantigen Cancer Vaccine Market Size/Share Worth USD 1.98 Billion by 2034 at a 15.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, June 10, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Neoantigen Cancer Vaccine Market Size, Trends and Insights By Product...